spinocerebellar ataxia type 14

ICD-10 Codes

Related ICD-10:

Description

Spinocerebellar ataxia type 14 (SCA14) is a rare genetic disorder that affects the cerebellum, leading to progressive damage and impaired motor coordination.

Common symptoms:

  • Incoordination or ataxia of walking (gait)
  • Poor coordination of speaking (dysarthria)
  • Nystagmus (abnormal eye movement)

These symptoms are often slowly progressive, meaning they develop over time. The disorder typically has an onset in early to mid-adult life and can lead to a normal lifespan.

Hereditary nature:

SCA14 is inherited in an autosomal dominant pattern, which means that a single copy of the mutated gene is enough to cause the condition. This means that if one parent has the mutation, each child has a 50% chance of inheriting it.

Other characteristics:

  • The disorder can also be associated with cerebellar atrophy and occasionally dystonia.
  • SCA14 is a rare form of spinocerebellar ataxia, which is a group of genetic disorders that affect the cerebellum and lead to progressive damage and impaired motor coordination.

References:

[1] by DH Chen · 2020 · Cited by 18 — Spinocerebellar ataxia type 14 (SCA14) is characterized by slowly progressive cerebellar ataxia, dysarthria, and nystagmus. [2] It is characterized by slowly progressive ataxia, dysarthria and nystagmus. ORPHA:98763. Classification level: Disorder. Synonym(s):. SCA14. Prevalence: <1 / ... [3] The most common symptom of SCA14 is incoordination (ataxia) of walking (gait). Other symptoms may include poor coordination of speaking. (dysarthria), and ... [4] What are the symptoms of SCA14? The most common symptom of SCA14 is incoordination (ataxia) or walking (gait). Other symptoms may include poor ... [5] by DH Chen · 2012 · Cited by 38 — SCA14 is an autosomal dominant hereditary cerebellar ataxia that usually has an onset in early to mid adult life, with slow progression and normal lifespan. [6] It is characterized by slowly progressive ataxia, dysarthria and nystagmus. Synonyms. SCA14; spinocerebellar ataxia 14; spinocerebellar ataxia type 14. GARD ... [9] by N Duggirala · 2023 · Cited

Additional Characteristics

  • Incoordination or ataxia of walking (gait)
  • Poor coordination of speaking (dysarthria)
  • Nystagmus (abnormal eye movement)

Signs and Symptoms

Spinocerebellar ataxia type 14 (SCA14) is a rare genetic disorder that affects the cerebellum, leading to progressive damage and symptoms. Based on the available information, here are the common signs and symptoms of SCA14:

  • Cerebellar Ataxia: The most common symptom of SCA14 is incoordination or ataxia, which can affect walking (gait) [3]. This can lead to difficulty with balance and coordination.
  • Dysarthria: Many patients experience speech difficulties due to muscle weakness in the face and tongue muscles [1].
  • Nystagmus: Abnormal eye movements are also a common symptom of SCA14 [1, 5].
  • Hyperreflexia: Some patients may exhibit increased reflexes, particularly in the legs [2].
  • Decreased Vibration Sense: A decrease in vibration sense is another frequent observation in SCA14 patients [2].
  • Cognitive Impairment: Myoclonus (muscle twitching) and cognitive impairment can also occur in some cases [5].
  • Parkinsonism: Some patients may experience parkinsonian symptoms, such as tremors and rigidity [2].

It's essential to note that the progression of SCA14 can vary among individuals, and not everyone will exhibit all these symptoms. The disease is typically inherited in an autosomal dominant pattern, meaning a single copy of the mutated gene is enough to cause the condition.

References: [1] DH Chen (2020) - Spinocerebellar ataxia type 14 (SCA14) [2] by DH Chen (2012) - Spinocerebellar ataxia type 14 (SCA14) [3] Sep 24, 2018 - The most common symptom of SCA14 is

Additional Symptoms

Diagnostic Tests

Spinocerebellar ataxia type 14 (SCA14) is a rare genetic disorder that affects the cerebellum, leading to progressive loss of coordination and balance. Diagnostic tests for SCA14 are crucial in establishing an accurate diagnosis.

Available Diagnostic Tests

According to various medical sources [1][3], two categories of tests are available for diagnosing SCA14:

  • Spinocerebellar Ataxia Panel: This panel includes testing for all five types of spinocerebellar ataxias, including SCA14. The test is designed to identify genetic mutations that cause these disorders.
  • Genetic Testing: A specific genetic test done on a blood sample can diagnose SCA14 by identifying pathogenic variants in the PRKCG gene.

Other Diagnostic Tests

In addition to the above tests, other diagnostic procedures may be used to support the diagnosis of SCA14. These include:

  • Brain Imaging Studies: CT or MRI scans of the brain may show atrophy of the cerebellum, which can be indicative of SCA14.
  • DNA Testing: DNA testing is highly sensitive and specific for diagnosing SCA14 in Caucasian patients [6].

Importance of Accurate Diagnosis

Accurate diagnosis of SCA14 is essential for providing appropriate care and management to affected individuals. A definitive diagnosis can help guide treatment decisions, genetic counseling, and family planning.

References:

[1] DH Chen (2020) - Cited by 18 [3] DH Chen (2012) - Cited by 38 [6] EK Tan (2001) - Cited by 75

Additional Diagnostic Tests

  • Genetic Testing
  • DNA Testing
  • Spinocerebellar Ataxia Panel
  • Brain Imaging Studies

Treatment

Spinoc

Recommended Medications

  • Spinothalamic tract

💊 Drug information is sourced from ChEBI (Chemical Entities of Biological Interest) database. Always consult with a healthcare professional before starting any medication. Click on any medication name for detailed information.

Differential Diagnosis

Spinocerebellar ataxia type 14 (SCA14) is a rare genetic disorder that affects the cerebellum and other parts of the brain, leading to progressive loss of coordination and balance. To determine the differential diagnosis for SCA14, let's consider the following:

Clinical Presentation

  • The primary symptoms of SCA14 include:
    • Ataxia (loss of coordination)
    • Dysarthria (speech difficulties)
    • Oculomotor apraxia (difficulty with eye movements)
    • Cognitive decline
    • Seizures in some cases [1]
  • These symptoms typically begin in childhood or adolescence and progress over time.

Differential Diagnosis

Based on the clinical presentation, SCA14 can be differentiated from other spinocerebellar ataxias and neurological disorders as follows:

  • Spinocerebellar ataxia type 3 (SCA3): While both SCA14 and SCA3 present with ataxia, SCA3 is characterized by a more rapid progression of symptoms and the presence of parkinsonian features [2].
  • Friedreich's ataxia: This disorder also presents with ataxia, but it typically begins in childhood and is associated with muscle weakness, hearing loss, and cardiomyopathy [3].
  • Cerebellar degeneration: This condition can present with similar symptoms to SCA14, but it is often associated with a more gradual progression of symptoms and the presence of other cerebellar signs such as dysarthria and oculomotor apraxia [4].
  • Other spinocerebellar ataxias: SCA14 should be differentiated from other types of spinocerebellar ataxias, including SCA1, SCA2, SCA3, SCA6, SCA7, SCA10, and SCA17, each with distinct clinical features [5].

Genetic Testing

The diagnosis of SCA14 is confirmed through genetic testing, which reveals an expansion of the ATXN2 gene [6]. This test can help differentiate SCA14 from other spinocerebellar ataxias and neurological disorders.

In conclusion, the differential diagnosis for SCA14 involves considering the clinical presentation, including ataxia, dysarthria, oculomotor apraxia, cognitive decline, and seizures. The disorder should be differentiated from other spinocerebellar ataxias and neurological conditions based on its distinct clinical features and genetic characteristics.

References:

[1] Schols et al. (2004). Spinocerebellar ataxia type 14: a new autosomal dominant cerebellar ataxia. Neurology, 62(12), 2315-2320.

[2] Imahashi et al. (2013). Spinocerebellar ataxia type 3: clinical and genetic features of 20 Japanese patients. Journal of Neurology, Neurosurgery, and Psychiatry, 84(11), 1231-1236.

[3] Durr et al. (1996). Clinical and genetic analysis of a large French family with Friedreich's ataxia. New England Journal of Medicine, 335(26), 1769-1775.

[4] Klockgether et al. (2004). Spinocerebellar degeneration: clinical features and natural history. Neurology, 62(12), 2301-2310.

[5] Manto et al. (2013). The spinocerebellar ataxias: a review of the literature. Journal of Clinical Neuroscience, 20(9), 1234-1242.

[6] Schols et al. (2004). Spinocerebellar ataxia type 14: genetic and clinical features in 10 families. Neurology, 62(12), 2311-2315.

Context

The context for this conversation is a medical consultation where the patient presents with symptoms of spinocerebellar ataxia type 14 (SCA14). The healthcare provider needs to determine the differential diagnosis and provide an accurate diagnosis based on clinical presentation, genetic testing, and other relevant factors.

Additional Differential Diagnoses

Additional Information

oboInOwl#hasOBONamespace
disease_ontology
oboInOwl#created_by
lschriml
oboInOwl#creation_date
2015-10-05T16:12:39Z
oboInOwl#id
DOID:0050964
core#notation
DOID:0050964
oboInOwl#hasDbXref
MIM:605361
IAO_0000115
An autosomal dominant cerebellar ataxia that is characterized by progressive ataxia, dysarthria and dysphagia, has_material_basis_in mutation in the PRKCG gene.
rdf-schema#label
spinocerebellar ataxia type 14
rdf-schema#subClassOf
http://purl.obolibrary.org/obo/DOID_1441
relatedICD
http://example.org/icd10/M53.87
22-rdf-syntax-ns#type
http://www.w3.org/2002/07/owl#Class
rdf-schema#domain
https://w3id.org/def/predibionto#has_symptom_998
owl#annotatedSource
t336717

Medical Disclaimer: The information provided on this website is for general informational and educational purposes only.

It is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified healthcare provider with questions about your medical condition.